Wednesday, December 11, 2013 | 7:00 PM - 8:30 PM
Featuring: Peter Fenwick, Kevin Nelson, Mary Neal, Sam Parnia
Moderator: Steve Paulson
What happens when we die? Recent medical advances have led to increased reports of "out of body" or "near death" experiences. Can these experiences be explained, and what can we learn from the transformative accounts of those who have nearly died?
Wednesday, February 5, 2014 | 7:00 PM - 8:30 PM
Featuring: Allan Kellehear, Jeffrey J. Kripal, and Lani Leary
Moderator: Steve Paulson
How do we cope with the inevitability of our mortality? Experts in psychology, philosophy and sociology come together to share a multicultural perspective on death, dying, and what lies beyond.
Thursday, November 21, 2013 | 8:00 AM - 5:00 PM
Keynote Speaker: Sally Tinkle (IDA/Science and Technology Policy Institute)
Featured Speakers: Yechezkel (Chezy) Barenholz (Hebrew University-Hadassah Medical School), Raj Bawa (Bawa Biotech LLC and Rensselaer Polytechnic Institute), Gerrit Borchard (University of Geneva, University of Lausanne), Ricardo Carvajal (Hyman, Phelps & McNamara, P.C.), Neil Desai (Abraxis Bioscience, A wholly owned subsidiary of Celgene Corporation), Rogério Gaspar (University of Lisbon), Patrick Hunziker (University Hospital Basel), Laurent Levy (Nanobiotix), Scott E. McNeil (Nanotechnology Characterization Laboratory – Frederick National Laboratory for Cancer Research), Stefan Mühlebach (Vifor Pharma Ltd. and University of Basel), Ritu Nalubola (US Food and Drug Administration), Lawrence Tamarkin (Cytimmune)
Explore regulatory challenges in the nascent field of nanomedicines including the relevance and adequacy of existing frameworks, availability and expertise of regulators, and safety concerns.
Tuesday, November 12, 2013 | 7:00 PM - 8:30 PM
Featuring: Christopher Comfort, Barbara Coombs Lee, Sam Shemie, and Mildred Z. Solomon
Moderator: Steve Paulson
As lifesaving technologies continue to advance, how should medical and financial resources be used to prolong the lives of patients suspended between life and death? Panelists weigh the legal, ethical, and social implications of such decisions.
Monday, November 11, 2013 | 6:30 PM - 8:00 PM
Speakers: Julia Hirschberg (Columbia University), Kelly Hoey (Women Innovate Mobile), Cecilia Marta (Sanofi-Aventis), Susan Hazels Mitmesser (NBTY), Jin Montclare (NYU Poly)
Please join us for our launch event to meet fellow women in STEM from the greater NYC metropolitan area. The first hour will be an open forum to present and solicit ideas for future NYWiSTEM programming. The second hour will be a networking mixer.
November 6 - 7, 2013
Organizers: Alan Cross (AstraZeneca), Sonya Dougal (formerly at The New York Academy of Sciences), Howard Feldman (University of British Columbia), Surya Kolluri (Bank of America), Ian Kremer (Leaders Engaged on Alzheimer's Disease), Tetsuyuki Maruyama (Takeda), Richard C. Mohs (Eli Lilly and Company), Jeffrey S. Nye (Janssen R&D), Ronald C. Petersen (Mayo Clinic), Gregory A. Petsko (Weill Cornell Medical College), Andrea Pfeifer (AC Immune), Thomas Rooney (Sanofi), Darryle D. Schoepp (Merck and Company, Inc.), Diane Stephenson (Critical Path Institute), Rudolph E. Tanzi (Harvard Medical School), John Q. Trojanowski (University of Pennsylvania), Diana L. van de Hoef (The New York Academy of Sciences), George Vradenburg (The Global CEO Initiative on Alzheimer's Disease), Michael Weiner (University of California, San Francisco), Michael Krams (Janssen R&D)
NIA Technical Advisor: Neil Buckholtz (National Institute on Aging/NIH)
This conference will convene leading industry, academic, and government stakeholders to discuss how to prevent and effectively treat Alzheimer's by 2025, by coordinating with governmental efforts to build research resources, reengineer our current drug development and evaluation systems, and identify innovative technologies and financing models. The outcome of this meeting will comprise a research agenda that will delineate the pathways needed to effectively treat and prevent Alzheimer's disease by 2025.
Speaker: Jeanne Garbarino (The Rockefeller University)
This eBriefing looks at how crowdfunding is being used for scientific research and explores whether it could become a more substantial source of funding.
Organizers: Sharon R. Akabas (Columbia University), Gerald Friedman (The Icahn School of Medicine at Mount Sinai), Martin Kohlmeier (University of North Carolina at Chapel Hill), Charlotte A. Pratt (National Institutes of Health), Gwen Twillman (American Society for Nutrition), Mandana Arabi (The Sackler Institute for Nutrition Science), and Brooke Grindlinger (The New York Academy of Sciences)
Nutrition training for medical professionals is often inadequate. This eBriefing explores how to improve curricula.
Edited by Richard S. Ostfeld
and William H. Schlesinger
(Cary Institute of Ecosystem Studies, Millbrook, New York)
The sixth installment of this Annals series presents a diverse collection of timely reviews in conservation biology.
Special Guest Speaker: Thomas Farley (New York City Department of Health and Mental Hygiene)
This eBriefing explores novel HIV prevention programs and therapies among gay, bisexual, and other men who have sex with men.
With our economy a shambles and our environment threatened, is there any reason to be optimistic about the future? Matt Ridley says there's scientific proof to say we should be.
According to the New York City Panel on Climate Change, global warming could have a big impact on the five boroughs. Three experts discuss the Panel's recent findings, and tell us what weather and policy changes to expect.
Richard Dawkins launches his newest book in the third S&C Provocative Thinkers in Science event. He argues evolution is an indisputable fact, despite nearly half of Americans believing the opposite.
Translational Medicine Initiative
The Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.
Learn more at www.nyas.org/TransMed.